CIK 0000014272
- Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 220790350
- Phone
- +1 609-252-4621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-01 | Santiago Karen Murphy SVP & Controller | Exercise or conversion · Restricted Stock Units | −642 | 0 | ||
| 2020-08-31 | Caforio Giovanni Chairman and CEO | Sale | −39,840 | $62.70 | $2.5M | 445,584.33 |
| 2020-08-17 | Eid Joseph SVP,Head Glob. Medical Affairs | Sale | −5,327 | $64.00 | $341K | 2,534 |
| 2020-08-13 | LEUNG SANDRA EVP, General Counsel | Sale | −141,420 | $63.24 | $8.9M | 432,744.33 |
| 2020-08-01 | Elkins David V EVP, Chief Financial Officer | Exercise or conversion | +46,402 | 80,698 | ||
| 2020-08-01 | Elkins David V EVP, Chief Financial Officer | Shares withheld for taxes | −25,916 | $58.66 | $1.5M | 54,782 |
| 2020-08-01 | Elkins David V EVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −46,402 | 46,403 | ||
| 2020-07-01 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion | +9,356 | 9,356 | ||
| 2020-07-01 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Shares withheld for taxes | −4,463 | $59.43 | $265K | 4,893 |
| 2020-07-01 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion · Restricted Stock Units | −9,356 | 28,069 | ||
| 2020-07-01 | Santiago Karen Murphy SVP & Controller | Exercise or conversion | +1,069 | 8,115 | ||
| 2020-07-01 | Santiago Karen Murphy SVP & Controller | Shares withheld for taxes | −367 | $59.43 | $22K | 7,748 |
| 2020-07-01 | Santiago Karen Murphy SVP & Controller | Exercise or conversion · Restricted Stock Units | −1,069 | 3,208 | ||
| 2020-06-30 | Samuels Theodore R. II Director | Grant or award · Deferred Share Units | +552.72 | $58.80 | $32K | 20,049.36 |
| 2020-06-30 | Storch Gerald L Director | Grant or award · Deferred Share Units | +579.35 | $58.80 | $34K | 57,606.06 |
| 2020-06-30 | Vousden Karen H Director | Grant or award · Deferred Share Units | +164.75 | $58.80 | $10K | 14,077.3 |
| 2020-06-30 | YALE PHYLLIS R Director | Grant or award · Deferred Share Units | +488.95 | $58.80 | $29K | 4,890.6 |
| 2020-06-30 | GROBSTEIN MICHAEL Director | Grant or award · Deferred Share Units | +114.47 | $58.80 | $7K | 87,898.19 |
| 2020-06-30 | Haller Julia A Director | Grant or award · Deferred Share Units | +528.89 | $58.80 | $31K | 4,930.55 |
| 2020-06-30 | LACY ALAN J Director | Grant or award · Deferred Share Units | +212.59 | $58.80 | $12K | 78,952.19 |
Page 89 of 90 · 1,795 trades